Alibaba
BABA
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Oracle
ORCL
5
ASML Holding
ASML
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.